KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Notes Payables (2023 - 2025)

Cardlytics (CDLX) has disclosed Notes Payables for 3 consecutive years, with $46.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Notes Payables rose 0.61% year-over-year to $46.1 million, compared with a TTM value of $46.1 million through Sep 2025, up 0.61%, and an annual FY2024 reading of $45.9 million, changed N/A over the prior year.
  • Notes Payables was $46.1 million for Q3 2025 at Cardlytics, roughly flat from $46.0 million in the prior quarter.
  • Across five years, Notes Payables topped out at $46.1 million in Q3 2025 and bottomed at $30.0 million in Q2 2023.
  • Average Notes Payables over 3 years is $41.4 million, with a median of $45.9 million recorded in 2024.
  • The sharpest move saw Notes Payables surged 52.63% in 2024, then increased 0.61% in 2025.
  • Year by year, Notes Payables stood at $30.0 million in 2023, then surged by 52.88% to $45.9 million in 2024, then increased by 0.45% to $46.1 million in 2025.
  • Business Quant data shows Notes Payables for CDLX at $46.1 million in Q3 2025, $46.0 million in Q2 2025, and $45.9 million in Q1 2025.